InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Friday, 08/12/2016 10:32:02 AM

Friday, August 12, 2016 10:32:02 AM

Post# of 5006
Proliferative Vitreoretinopathy (PVR) Therapeutics Development Pipeline Review, H1 2016 Featuring Novartis, Promedior & RXi Pharmaceuticals – Research and Markets
http://www.businesswire.com/news/home/20160412006699/en/Proliferative-Vitreoretinopathy-PVR-Therapeutics-Development-Pipeline-Review

I think our frustrations will be rewarded in due time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News